Management of punding in Parkinson’s disease: an open-label prospective study

被引:0
|
作者
A. Fasano
L. Ricciardi
M. Pettorruso
A. R. Bentivoglio
机构
[1] Università Cattolica del Sacro Cuore Largo Agostino Gemelli,Istituto di Neurologia
[2] 8,Department of Neurosciences, Psychiatry and Anaesthesiological Science
[3] Neuromed Institute,Department of Psychiatry
[4] University of Messina,undefined
[5] Catholic University of Sacred Heart,undefined
来源
Journal of Neurology | 2011年 / 258卷
关键词
Amantadine; Parkinson’s disease; Punding; Therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Punding, a peculiar stereotyped behavior characterized by intense fascination with complex, excessive, non-goal-oriented, repetitive activities, is a quite rare condition complicating Parkinson’s disease (PD). It is triggered by dopaminergic therapy and could have a strong impact on patient quality of life. No study has specifically investigated medical management of this condition, and only a few anecdotal reports have provided therapeutic hints. Given the suggested similarities to drug-induced dyskinesias, we have previously suggested a multistep algorithm for management of punding. We conducted a prospective open-label study on ten PD punders aimed at testing its validity. In two cases, reduction of levodopa therapy was efficacious; amantadine was effective in controlling punding in four cases; in the remaining cases, quetiapine was employed, with mild efficacy in two cases.
引用
收藏
页码:656 / 660
页数:4
相关论文
共 50 条
  • [1] Management of punding in Parkinson's disease: an open-label prospective study
    Fasano, A.
    Ricciardi, L.
    Pettorruso, M.
    Bentivoglio, A. R.
    JOURNAL OF NEUROLOGY, 2011, 258 (04) : 656 - 660
  • [2] SSRIs do not worsen Parkinson's disease: Evidence from an open-label, prospective study
    Dell'Agnello, G
    Ceravolo, R
    Nuti, A
    Bellini, G
    Piccinni, A
    D'Avino, C
    Dell'Osso, L
    Bonuccelli, U
    CLINICAL NEUROPHARMACOLOGY, 2001, 24 (04) : 221 - 227
  • [3] Unilateral pallidothalamic tractotomy for akinetic-rigid Parkinson's disease: a prospective open-label study
    Horisawa, Shiro
    Fukui, Atsushi
    Yamahata, Hayato
    Tanaka, Yukiko
    Kuwano, Atsushi
    Momosaki, Oji
    Iijima, Mutsumi
    Nanke, Magi
    Kawamata, Takakazu
    Taira, Takaomi
    JOURNAL OF NEUROSURGERY, 2021, 135 (03) : 799 - 805
  • [4] Safinamide Improves Non-Motor Symptoms Burden in Parkinson's Disease: An Open-Label Prospective Study
    Santos Garcia, Diego
    Labandeira Guerra, Carmen
    Yanez Bana, Rosa
    Cimas Hernando, Maria Iciar
    Cabo Lopez, Iria
    Paz Gonalez, Jose Manuel
    Alonso Losada, Maria Gemma
    Gonzalez Palmas, Maria Jose
    Martinez Miro, Cristina
    BRAIN SCIENCES, 2021, 11 (03) : 1 - 15
  • [5] Safinamide Improves Non-Motor Symptoms Burden in Parkinson's Disease: An Open-label Prospective Study
    Santos Garcia, D.
    Labandeira, C.
    Yanez, R.
    Cimas Hernando, I.
    Cabo Lopez, I.
    Paz Gonzalez, J.
    Alonso Losada, G.
    Gonzalez Palmas, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2021, 28 : 163 - 163
  • [6] Open-Label Study of Pimavanserin Patients With Comorbid Parkinson's Disease and Depression
    Norton, J.
    Fredericks, D.
    Alva, G.
    Aldred, J.
    Coate, B.
    DeKarske, D.
    Cantillon, M.
    Owen, R.
    MOVEMENT DISORDERS, 2019, 34 : S68 - S69
  • [7] Laserlight cues for gait freezing in Parkinson's disease: An open-label study
    Donovan, S.
    Lim, C.
    Diaz, N.
    Browner, N.
    Rose, P.
    Sudarsky, L. R.
    Tarsy, D.
    Fahn, S.
    Simon, D. K.
    PARKINSONISM & RELATED DISORDERS, 2011, 17 (04) : 240 - 245
  • [8] Opicapone Improves Global Non-Motor Symptoms Burden in Parkinson's Disease: An Open-Label Prospective Study
    Santos Garcia, Diego
    Fernandez Pajarin, Gustavo
    Manuel Oropesa-Ruiz, Juan
    Escamilla Sevilla, Francisco
    Rahim Lopez, Raul Rashid Abdul
    Munoz Enriquez, Jose Guillermo
    BRAIN SCIENCES, 2022, 12 (03)
  • [9] Opicapone improves global non-motor symptoms burden in Parkinson's disease: an open-label prospective study
    Santos Garcia, D.
    Fernandez Pajarin, G.
    Oropesa Ruiz, J.
    Escamilla Sevilla, F.
    Rahim Lopez, R.
    Munoz Enriquez, G.
    MOVEMENT DISORDERS, 2022, 37 : S350 - S351
  • [10] EFFECTS OF ISTRADEFYLLINE FOR QUALITY OF LIFE IN PARKINSON'S DISEASE WITH FREEZING OF GAIT: A SINGLEARM, OPEN-LABEL, PROSPECTIVE, MULTICENTER STUDY
    Iijima, M.
    Orimo, S.
    Terashi, H.
    Suzuki, M.
    Hayashi, A.
    Shimura, H.
    Kitagawa, K.
    Okuma, Y.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E72 - E72